Ultragenyx Pharmaceutical Pre-Tax Income 2012-2024 | RARE
- Ultragenyx Pharmaceutical annual pre-tax income for 2023 was $-0.608B, a 13.29% decline from 2022.
- Ultragenyx Pharmaceutical annual pre-tax income for 2022 was $-0.702B, a 54.91% increase from 2021.
- Ultragenyx Pharmaceutical annual pre-tax income for 2021 was $-0.453B, a 144.38% increase from 2020.